Zinc is an essential heavy metal and is more abundant in human prostate and kidney than in other tissues. The effects of zinc on the invasion activity of human prostate and renal cancer cell lines, PC-3, LNCaP and SKRC-1, were investigated in vitro using a Transwell cell-culture chamber and were compared with specific protease inhibitors for MMPs, uPA and AP-N, respectively. The invasion activity of PC-3 cells was effectively suppressed by zinc and by all protease inhibitors in a dose-dependent manner. The invasion activity of LNCaP cells was almost unaffected by these inhibitors. In SKRC-1 cells, the invasion activity was strongly suppressed by MP03, although a moderate inhibition by zinc and bestatin was observed. The purified AP-N activity was strongly inhibited by zinc at a concentration similar to that suppressing the invasion activity of PC-3 cells and this inhibition by zinc was apparently competitive. Although the purified uPA activity was also inhibited by zinc, this inhibition was uncompetitive. AP-N was expressed abundantly on the membrane fraction of PC-3 cells among these cells tested, while its expression on the membrane fraction of SKRC-1 cells was weaker than that of PC-3 cells. The expression of uPA was also highest on the membrane fraction of PC-3 cells. These results suggest that AP-N and uPA may be involved in the invasion of human prostate cancer cells and that zinc probably participates in the invasion and metastasis of cancer cells through the regulation of the enzymatic activity of AP-N and uPA in human cancerous prostate.
The first step in metastasis is tumor cell invasion, involving penetration of the basement membranes by tumor cells that can locally initiate a proteolytic cascade. Metastasis of a primary tumor to vital organs is the dominant cause of cancer related deaths. 1) Tumor cell invasion is a complex process involving cell adhesion, motility (migration) and the degradation of tissue and extracellular matrix (ECM) barriers by different proteases secreted by tumor cells. Invasive malignant cells are able to degrade the extracellular matrix and basement membranes, presumably through the secretion of proteolytic enzymes, including matrix metalloproteinases (MMPs), urokinase-type plasminogen activator (uPA) and aminopeptidase N (AP-N). Unregulated secretion of these proteases has been implicated in tumor invasion and metastasis, suggesting that inhibitors for these proteases may be useful in preventing the invasion of malignant tumors.
Extracellular MMPs are zinc-dependent proteases that can initiate the degradation of ECM macromolecules, such as collagen and proteoglycans.
2) Proteolysis by MMPs is regulated by a family of naturally occurring endogenous proteinase inhibitors known as the tissue inhibitors of metalloproteinases (TIMPs).
3) Unbalanced production of MMPs and TIMPs by cancer cells and tumor stroma correlates with the malignant or metastatic phenotype. This unbalance has been found in serum and plasma of animals bearing experimental tumors and of human patients. 4, 5) In vivo and in vitro experimental models have suggested a major role for the uPA in tumor cell invasion and metastasis. 6) The uPA is a molecule of 50-54 kDa having two chains (A and B) and three linked domains: the amino terminal fragment, the kringle domain and the protease domain. The amino-terminus of uPA binds with high affinity to the uPA receptor (uPAR) for enhancing its proteolytic activity, a domain distinct from uPA enzymatically active center. 7) uPAR expression and regulation of the uPA activity at the tumor cell surface may be an important step in metastatic spread.
AP-N (CD13; EC 3. 4. 11. 2) is a cell surface glycoprotein with zinc-dependent exopeptidase activity. This enzyme cleaves neutral amino acids from the N-terminal of oligopeptides. It is known to be highly expressed on the brush border membranes of the small intestine and renal proximal tubules, 8) where it plays a role in the final steps of the digestion of small peptides. AP-N might also act as a corona virus receptor 9) and has been implicated in antigen processing. 10) Further reported functions of AP-N include the degradation of collagen type IV with a proposed role in tumor invasion.
11)
Zinc is an essential heavy metal and is a constituent of more than 200 enzymes in the human body. Zinc is reported to be crucial for the immune system, and zinc deficiency causes to a marked decline in immunological competence. 12) Although zinc plays an important role in nucleic acid metabolism, cell replication, tissue repair, and growth and is required for tumor growth, 13) the zinc levels in human prostate and kidney cancer tissues markedly decrease as compared with the surrounding normal tissues. 14, 15) It is unclear whether the decrease of zinc levels in these cancerous tissues relates to the progression of urological disease.
In the present study, we investigate the relationship of zinc to human urological cancer cell invasion, and then clarify the suppressive mechanisms of tumor cell invasion by zinc.
MATERIALS AND METHODS
Materials Matrigel (extracted from Engelbreth-HolmSwarm (EHS) sarcoma) was purchased from Collaborative Biomedical products (Bedford, Massachusetts, U.S.A.). Zinc acetate was used for all experiments. LNCaP and PC-3 cells were purchased from the American Type Culture Collection. SKRC-1 cells were kindly provided from Dr. Yoshikawa, Aichi Medical University (Aichi, Japan). MP03 as a potent inhibitor of MMP-2 and MMP-9, 16) UP-001 as a potent inhibitor of uPA, purified MMP-2 from normal human fibroblast and recombinant MMP-9 were a kind gift of Ono Pharmaceutical Co., Ltd. (Osaka, Japan). Purified uPA from human urine was a kind gift of JCR Pharmaceuticals Co., Ltd. (Ashiya, Japan). Purified AP-N from human prostate was used for experiments. Fluorogenic substrates for the proteases were purchased from Peptide Institute (Osaka, Japan). Bestatin was purchased from Sigma Chemicals (St. Louis, MO, U.S.A.). All other chemicals were of analytical grade.
Cell Culture PC-3 (androgen-independent) and LNCaP (androgen-dependent) cells, which were derived from metastases of human prostate adenocarcinoma, and SKRC-1 cells, which were derived from human renal carcinoma, were routinely cultured in Dulbecco's modified Eagle's medium (DMEM) containing 10% fetal calf serum under a humidified atmosphere with 5% CO 2 in air.
Cell Viability and Adhesion on Matrigel Cell viability and adhesion on Matrigel were assayed according to the methods reported by Iguchi et al.
17)
Wound Assay The wound assay was performed according to the methods reported by Goodman et al. 18) After wounding, PC-3 cell was treated with zinc and protease inhibitors for 24 h. The effects of zinc and protease inhibitors on the cell motility of PC-3 was evaluated by comparing to control results.
Invasion Assay The invasion activity of human urological cancer cells was assayed using a Transwell cell-culture chamber by the method of Albini et al. 19) The upper surface of the membrane with an 8.0 mm pore size (FALCON Labware) in a cell culture insert was coated with 5 mg Matrigel dissolved in phosphate-buffered saline (PBS) and dried at room temperature. Cells suspended in culture medium were seeded at a density of 3ϫ10 4 cells/well into the cell culture insert and the insert was placed onto a well filled with the same medium in a 24-well culture plate. Zinc and protease inhibitors were added into the insert and the plate was incubated for a certain period (PC-3; 24 h, LNCaP; 48 h, SKRC-1; 12 h) in a CO 2 incubator. After incubation, the filters were fixed with 5% glutaraldehyde and stained with Giemsa's solution (Merck). The cells on the upper surfaces of the filter were wiped out with cotton swabs. The cells that migrated to the lower surface of the membrane were counted under a microscope.
Assay for AP-N and uPA Activities AP-N and uPA activities were determined fluorometrically with Met-MCA and Glt-Gly-Arg-MCA, respectively, as substrates. The reaction mixture containing 50 ml of 100 mM substrate, 30 ml of 100 mM Tris-HCl buffer, pH 8.0, and 20 ml of enzyme solution was incubated at 37°C for 20 min. The enzyme reaction was terminated by the addition of 2 ml of 1 M acetic acid. The fluorescence intensity was measured using 380 and 460 nm excitation and emission wavelengths, respectively.
Assay for MMPs Activities Purified pro-MMP-2 was activated immediately prior to use by 1 mM 4-aminophenylmercuric acetate (APMA). MMP-2 and MMP-9 activities were determined fluorometrically with (7-methoxycoumarin-4-yl) acetyl (MOCAc)-Pro-Leu-Gly-Leu-A 2 pr (Dnp)-Ala-Arg-NH 2 as a substrate. The reaction mixture containing 50 ml of 27.6 mM substrate, 30 ml of 100 mM TrisHCl buffer, pH 7.5 containing 100 mM NaCl, 10 mM CaCl 2 , 0.01% NaN 3 and 0.05% Brij 35, and 20 ml of enzyme solution was incubated at 37°C for 30 min. The enzyme reaction was terminated by the addition of 2 ml of 0.1 M sodium acetate, pH 4.0. The fluorescence intensity was measured using 328 and 393 nm excitation and emission wavelengths, respectively.
Preparation of Antibodies 500 mg of antigen (purified AP-N and uPA) was emulsified with Freund's complete adjuvant and injected subcutaneously into female rabbits. Starting two weeks after the first injection, the same amount of the antigen emulsified with the Freund's incomplete adjuvant was administered subcutaneously three times at two weeks intervals. The IgG fraction was prepared from the antiserum by ammonium sulfate fractionation, DEAE cellulose and protein A Sepharose chromatographies.
Western Blot Analysis One microgram each of purified AP-N and uPA were subjected to electrophoresis with an 8% for AP-N and a 15% for uPA SDS-polyacrylamide gel under reducing conditions, respectively. 45 mg of the cytosol and membrane fractions resolved in the gel were then transferred to a nitrocellulose membrane. The membranes were incubated with a polyclonal antibody against the purified AP-N and uPA, respectively. The antigen-antibody complex was detected with a secondary antibody, goat anti-rabbit IgG conjugated with horseradish peroxidase, and visualized with 4-chloro-1-naphthol as a substrate of peroxidase.
Statistical Analysis The significance of differences between groups was calculated by applying the Student's t-test.
RESULTS
The various proteases, MMP-2, MMP-9, uPA and AP-N, which can degrade the basement membranes are known to relate to tumor cell invasion. Since zinc is more abundant in human prostate and kidney than in other tissues, the effects of zinc and protease inhibitors on the invasion activity of human urological cancer cells, PC-3, LNCaP, and SKRC-1, were investigated in vitro using a Transwell cell-culture chamber coated with Matrigel. As shown in Fig. 1 , the invasion activity of PC-3 cells was effectively suppressed by zinc (a) and by all protease inhibitors, bestatin (b), UP-001 (c) and MP03 (d), in a dose-dependent manner. In contrast, the invasion activity of LNCaP cells was unaffected. The invasion activity of SKRC-1 cells was strongly suppressed by MP03 and weakly suppressed by zinc and bestatin compared with that of PC-3 cells. Although we investigated the effects of zinc and protease inhibitors on viability, adhesion ability, and motility of human urological cancer cells, PC-3, LNCaP and SKRC-1, no effect on these properties was observed. When we used serum-free medium to perform the invasion assay, the cell lines did not adhere on Matrigel. However, the adhesion ability of PC-3 and SKRC-1 cells on Matrigel was recovered by adding zinc to serum-free medium. This response was dose-dependent. This phenomenon was not observed with copper and manganese. Zinc had no effect on the adhesion ability of LNCaP cells.
The effects of zinc and protease inhibitors on the enzymatic activity of purified proteases were assessed to investigate the suppressive mechanisms of human urological cancer cell invasion by zinc. As shown in Table 1 , the purified AP-N activity was strongly inhibited by zinc and bestatin of which the concentration was similar to that suppressing the invasion activity. This inhibition for the purified AP-N activity by zinc and bestatin was apparently competitive with a K i value calculated to be 11.2 mM and 2.0 mM, respectively. In this study, the purified uPA activity was strongly inhibited by UP-001 (IC 50 ϭ0.3 mM), which was a specific inhibitor of uPA but not tPA (IC 50 Ͼ3 mM), and also effectively inhibited by zinc. This inhibition for the purified uPA activity by zinc was apparently uncompetitive with a K i value calculated to be 21.4 mM. The purified MMP-2 and MMP-9 activities were only inhibited by MP03, a specific inhibitor of MMP-2 and MMP-9, but not MMP-1, MMP-7, and MMP-3, although they were unaffected by zinc.
Since we demonstrated here that the inhibition for the purified AP-N and uPA activities by zinc was related to the suppression of PC-3 and SKRC-1 cell invasion, we further investigated the localization of both proteases in human urological cancer cells. In this study, we used Met-MCA as a substrate to evaluate the enzymatic activity of AP-N in human urological cancer cells. The enzymatic activity for Met-MCA was observed in the cytosol and membrane fractions of three cancer cells although the activity in the membrane fraction of LNCaP cells was lower than that in other fractions. The specific activity for Met-MCA on the membrane fraction of PC-3 cells was determined to be 9 nmol/ min/mg protein and this activity was about 1.3 times higher than that of SKRC-1 cells. However, this activity does not represent exactly the AP-N activity because Met-MCA used as a substrate is not a specific substrate for AP-N. Therefore, we performed a western blot analysis to detect the specific AP-N expression in the each fraction of these cells. As shown in Fig. 2a , AP-N was abundantly expressed on the membrane fraction of PC-3 cells, while AP-N expression was found to be weaker on the membrane fraction of SKRC-1 cells than that of PC-3 cells. AP-N expression was almost undetectable on the membrane fraction of LNCaP cells. Although the enzymatic activity for Met-MCA was observed in the cytosol fractions of these cells, AP-N expression was not Fig. 2b , the expression of uPA was also abundant on the membrane fraction of PC-3 cells, while it was almost undetectable on the membrane fraction of LNCaP and SKRC-1 cells. The specific activity for uPA on the membrane fraction of PC-3 cells was determined to be 40 pmol/min/mg protein and this activity was about 4 times higher than that of LNCaP and SKRC-1 cells. The enzymatic activity of uPA on the membrane fraction of PC-3 cells was highest among these cells tested, according as the result that uPA expression was observed only in this fraction of the cells.
DISCUSSION
The expression and secretion of proteases from tumor cells increases in the invasive process of the cells for promoting tumor metastasis to different organs. We demonstrated in this report that the specific inhibition of purified AP-N and uPA activities by zinc led to the suppression of human urological cancer cell invasion, and the expression and enzymatic activity of both proteases related to the suppressive potential of human urological cancer cell invasion by zinc. In fact, the invasion activity of PC-3 cells was effectively suppressed by zinc because both AP-N and uPA was expressed abundantly on the membrane fraction of PC-3 cells among the human urological cancer cells tested. Our results showed that the enzymatic activities of purified MMPs were not affected by zinc, suggesting strongly that MMPs are not related to the suppressive mechanisms of human urological cancer cell invasion by zinc. We also observed here that PC-3 and SKRC-1 cells lost the ability to adhere on Matrigel in serum-free medium and that this ability was recovered by the addition of zinc, supporting the idea that zinc helps the adhesion ability of PC-3 and SKRC-1 cells on Matrigel. Zinc was reported to increase the urokinase receptor (uPAR)-mediated adhesion of myelomonocytic cells to vitronectin, whereas other divalent cations had weak effects. 20) These findings suggest the possibility that zinc controls the invasion and adhesion of tumor cells through the regulation of the AP-N and uPA activities in human prostate and kidney.
Zinc is an essential element for humans, and is more abundant in prostate and kidney than in other tissues. In the male body the physiological actions of zinc include, a contribution to formation of spermatozoa 21) and testis growth 22) and the metabolism of androgens. 23) Normal and hyperplastic prostate tissues were reported to accumulate zinc up to a concentration of around 9 mM. 24) The zinc levels in human prostate cancerous tissues markedly decrease as compared with the surrounding normal tissues, 14) suggesting that a high concentration of zinc is not required for human prostatic tumor growth. Thus, we speculate that there are close relationships between zinc and physiological functions in normal and hyperplastic prostate tissues. Zinc predominantly (Ͼ95%) binds to high molecular weight ligands such as metalloenzymes, metalloproteins, nucleoproteins and nucleic acids, suggesting that most of the zinc in humans will bind to these ligands. 25) Therefore, the concentration of free, non-binding, zinc would be expected to be a few hundreds micromolar, although in human prostate it has not been determined. Similar to the results of our study, human glandular kallikrein 2 (hK2) activity was strongly inhibited by zinc at a few micromolar concentration, suggesting that the decrease of zinc in human prostate cancer may lead to the activation of hK2 activity. 26) HK2 is a serine protease expressed by the prostate gland and may be of importance in the progression of prostate cancer because hk2 is able to activate some proteolytic enzymes. Thus, zinc existing abundantly in normal and hyperplastic prostate may protect against the invasion of tumor cells by inhibiting the enzymatic activity of AP-N and uPA. Although the zinc levels in human renal cancer tissues are also markedly decreased as compared with the surrounding normal tissues, 15) the invasion activity of SKRC-1 cells was less weakly effected by zinc than that of PC-3 cells. Therefore, we must further investigate whether there are close relationships between zinc and physiological functions in human renal cancerous tissues.
The expression level and enzymatic activities of MMPs were not evaluated in this study because there is no inhibition of purified MMPs activities by zinc. When the effects of the combined protease inhibitors on PC-3 cell invasion were investigated, the suppression by the inhibitors combined with zinc and MP03 was more effective than the other combined protease inhibitors, such as bestatin and MP03, UP-001 and MP03. This implies that AP-N, uPA and MMPs are involved in the tumor cell invasion of PC-3 cells, but it is unclear from this study what proteases mainly participate in the invasion process of PC-3 cells. The invasion activity of LNCaP cells was not suppressed by zinc or any of the protease inhibitors, suggesting that the secretion and expression levels of proteases such as MMP-2, MMP-9, uPA and AP-N in LNCaP cells were very low compared with PC-3 cells, although both cells are derived from a human prostatic adenocarcinoma. In fact, we showed here that the expression and enzymatic activity of AP-N and uPA on the membrane of LNCaP cells were the weakest in the three of human urological cancer cell lines investigated. Although the relationship of AP-N and uPA to SKRC-1 cell invasion was very low compared with that of PC-3 cells, the invasion activity of PC-3 and SKRC-1 cells was effectively suppressed by MP03 in similar manner, suggesting that the relation of AP-N and uPA to SKRC-1 cell invasion is weaker than that of MMPs.
In conclusion, the present study demonstrated that the purified AP-N and uPA associated with tumor cell invasion were strongly inactivated by zinc, and that the expression of both proteases is related to the suppressive potential of human urological cancer cell invasion by zinc. These find- One microgram of the purified protease and 45 mg of the cytosol (C) and membrane (M) fractions were separated by electrophoresis with 8% (a) and 15% (b) SDSpolyacrylamide gel, respectively. After the proteins in the gel were transferred to a nitrocellulose membrane by electroblotting, AP-N and uPA were probed with the antibody against the purified AP-N from human prostate and uPA from human urine, respectively.
ings suggest that the high expression of AP-N and uPA in human prostate cancer may play an important role in the invasion and metastasis of prostate cancer cells.
